Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
•
Medical Oncology
How do you treat encapsulated papillary carcinoma of the breast after lumpectomy with negative margins?
Do you recommend observation, APBI, whole breast or whole breast with low axilla treatment?
Answer from: Radiation Oncologist at Community Practice
Encapsulated papillary carcinoma behave like DCIS and we use the same principles as we would use for managing DCIS.
Comments
Radiation Oncologist at Kaiser Permanente
Do you recommend similar margins to pure DCIS, giv...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
Accept no tumor at ink. The issue is more about th...
10353
10357
Sign in or Register to read more
5173
Related Questions
What is the appropriate approach to manage a patient with triple-negative, locally advanced breast cancer (LN+) who progresses on neoadjuvant chemo-immunotherapy (KEYNOTE-522 regimen)?
Given the final publication of NSABP B-51, for which patients meeting trial eligibility would you still recommend regional nodal irradiation?
How would you treat a young breast cancer patient with limited nodal involvement and an isolated sternal oligometastasis at diagnosis?
What are your top takeaways in Breast Cancer from ASTRO 2024?
Does delay to the time of lumpectomy impact your decision to omit radiation?
What are your top takeaways in Medical Oncology from SABCS 2024?
Do you recommend self-breast exams to your patients with history of breast cancer in addition to imaging surveillance?
In cT4aN0 triple negative breast cancer would you still recommend PMRT if pCR, ypT0N0(sn), after neoadj chemo is achieved?
How would you treat a patient with HER2 positive CNS only progression on fam-trastuzumab which had previously progressed on tucatinib/capecitabine/trastuzumab, and has failed both SRS and WBRT?
What are your top takeaways in Breast Cancer from ESMO 2024?
Do you recommend similar margins to pure DCIS, giv...
Accept no tumor at ink. The issue is more about th...